ARATANA THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 23rd, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of September 6, 2012 (the “Effective Date”) by and between ARATANA THERAPEUTICS, INC. (the “Company”) and Steven St. Peter (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
SECOND AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • May 23rd, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT (the “Agreement”) is made and entered into as of December 28, 2012, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), each of the holders of Series C Preferred Stock (as defined below) listed on Exhibit A hereto (the “Series C Preferred Holders”), each of the holders of Series B Preferred Stock (as defined below) listed on Exhibit B hereto (the “Series B Preferred Holders”), each of the holders of Series A Preferred Stock (as defined below) listed on Exhibit C hereto (the “Series A Preferred Holders”), each of the holders of Series A-1 Preferred Stock (as defined below) listed on Exhibit D hereto (the “Series A-1 Preferred Holders” and, together with the Series B Preferred Holders and the Series A Preferred Holders, the “Preferred Holders”), each of the holders of Common Stock (as defined below) listed on Exhibit E hereto (the “Common Holders” and collectively with the Series A Preferred Holders and
SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 23rd, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of December 28, 2012, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors set forth on the Schedule of Investors attached hereto as Exhibit A (each, an “Investor” and collectively, the “Investors”).
LEASELease • May 23rd, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Kansas
This Lease (the “Lease”) is made and entered into effective as of the 1st day of May 2013, by and between MPM Heartland House, LLC, a limited liability company organized under the laws of the State of Delaware (“Landlord”) and Aratana Therapeutics, Inc., a corporation organized under the laws of the Delaware (“Tenant”).
SERVICES AGREEMENTServices Agreement • May 23rd, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
SERVICES AGREEMENT (this “Agreement”) made effective as of May 1, 2013 among Aratana Therapeutics, Inc. (the “Company”) and MPM Asset Management LLC (“MPM”).
